BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel KR, Roberts JT, Barb AW. Allotype-specific processing of the CD16a N45-glycan from primary human natural killer cells and monocytes. Glycobiology 2020;30:427-32. [PMID: 31967297 DOI: 10.1093/glycob/cwaa002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Huang Z, Du K, Liu X, Li C, Wang D, Zhang Y, Wang C, Li J. Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity. Front Pharmacol 2022;13:900699. [DOI: 10.3389/fphar.2022.900699] [Reference Citation Analysis]
2 Barb AW. Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development. J Biol Chem 2021;296:100057. [PMID: 33172893 DOI: 10.1074/jbc.REV120.013168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Patel KR, Rodriguez Benavente MC, Lorenz WW, Mace EM, Barb AW. Fc γ receptor IIIa/CD16a processing correlates with the expression of glycan-related genes in human natural killer cells. J Biol Chem 2021;296:100183. [PMID: 33310702 DOI: 10.1074/jbc.RA120.015516] [Reference Citation Analysis]
4 Roushan A, Wilson GM, Kletter D, Sen KI, Tang W, Kil YJ, Carlson E, Bern M. Peak Filtering, Peak Annotation, and Wildcard Search for Glycoproteomics. Mol Cell Proteomics 2020;20:100011. [PMID: 33578083 DOI: 10.1074/mcp.RA120.002260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
5 Fogarty CA, Fadda E. Oligomannose N-Glycans 3D Architecture and Its Response to the FcγRIIIa Structural Landscape. J Phys Chem B 2021;125:2607-16. [PMID: 33661628 DOI: 10.1021/acs.jpcb.1c00304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]